William J. Holloway

Correlation of Fluconazole MICs with Clinical Outcome in Cryptococcal Infection

Ana Isabel Aller, Estrella Martín‐Mazuelos, Fernando Lozano et al. · Antimicrobial Agents and Chemotherapy · 2000 · 170 citations

Life Sciences, Infectious Diseases, Microbiology +15

In vitro activity of LY333328, an investigational glycopeptide antibiotic, against enterococci and staphylococci

Ruth A. Schwalbe, Angela C McIntosh, Sadaf Qaiyumi et al. · Antimicrobial Agents and Chemotherapy · 1996 · 70 citations · Full text

Life Sciences, Microbiology, Pharmacology +13

Evolution of Antifungal Susceptibility among<i>Candida</i>Species Isolates Recovered from Human Immunodeficiency Virus–Infected Women Receiving Fluconazole Prophylaxis

José A. Vázquez, Grace Peng, Jack D. Sobel et al. · Clinical Infectious Diseases · 2001 · 58 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +17

Efficacy Testing of Recombinant Human Immunodeficiency Virus (HIV) gp160 as a Therapeutic Vaccine in Early‐Stage HIV‐1–Infected Volunteers

Deborah L. Birx, Lawrence D. Loomis‐Price, Naomi Aronson et al. · The Journal of Infectious Diseases · 2000 · 57 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17

A Multicenter Comparative Study of Meropenem and Imipenem/Cilastatin in the Treatment of Complicated Urinary Tract Infections in Hospitalized Patients

Clair E. Cox, William J. Holloway, Ronald W. Geckler · Clinical Infectious Diseases · 1995 · 54 citations

Pharmacy, Infectious Diseases, Pharmacotherapy +9